Alantra has acted as financial advisor to CapMan Buyout, a leading Nordic private equity firm, on the sale of Pharmia Holding Oy (“Pharmia”) to Labomar S.p.A. (“Labomar”), an Italian-based CDMO and portfolio company of Charterhouse Capital Partners.
Founded in 1989, CapMan Oyj is a Helsinki-based private equity firm specializing in growth capital investments, middle-market buyouts, industry consolidation, credit, and mezzanine financing in unquoted companies.
Pharmia, headquartered in Finland, is the country’s leading Contract Development and Manufacturing Organization (CDMO). The company specializes in food supplements, probiotics, and medical devices, serving Finland’s leading pharmaceutical and consumer health companies.
Labomar is a full-service Italian CDMO with advanced expertise in nutraceutical products, medical devices, and foods for special medical purposes. Backed by Charterhouse, Labomar has been expanding its international footprint, and the acquisition of Pharmia marks a significant step in strengthening its position in Northern Europe.
Anders Björkell, Partner at CapMan Buyout commented: “The collaboration between your team, CapMan, and Pharmia’s management was excellent, and your strong sector expertise proved highly valuable. I am confident that Labomar is the ideal partner to support Pharmia’s continued growth.”
Charles Lanceley, Managing Director at Alantra, commented: “We are proud to have supported CapMan and Pharmia on this transaction, and to have completed our fifth deal in the European VMS CDMO space in the past nine months. This further reinforces our position as the leading advisor in the sector, built on our deep expertise and strong network of relationships.”
Jonas Bauréus, Managing Director at Alantra, added: “We were honored to work with CapMan in one of the largest transactions in the Nordic VMS space in recent years. We congratulate CapMan and all parties involved on a successful outcome.”
This transaction adds to Alantra’s strong momentum in the VMS CDMO sector, having advised Aminolabs Nutrition on the acquisition of Zoka Pharma, Venture Life Group plc on the sale of Biokosmes to BioDue S.p.A., Perrigo of the sale of Richard Bittner to DCC Healthcare, and Oakley Capital on the sale of Windstar Medical to Merz Lifecare.
cloud technology axon
Since Suma Capital’s entry in 2020, Gestcompost has quadrupled its E...
